Try our Advanced Search for more refined results

September 29, 2016

PAR PHARMACEUTICAL, INC. v. BURWELL et al

Track this case

Case Number:

1:16-cv-01933

Court:

District Of Columbia

Nature of Suit:

Other Statutory Actions

Judge:

Amit P. Mehta

Firms

Companies

Government Agencies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 30, 2016

    Par Sues FDA For Yanking Gout Drug's 180-Day Exclusivity

    Par Pharmaceutical is suing the U.S. Food and Drug Administration in D.C. federal court over its revoked 180-day exclusivity period for a generic gout drug, saying the agency incorrectly deemed its patent certifications faulty.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!